Roche Mantra Is “Pipeline, Pipeline, Pipeline;” R&D Surge Continues In 2008
Executive Summary
Roche spending increases on pharmaceutical research and development will continue to outpace sales gains in 2008, company executives said during the firm's fourth quarter financial review Jan. 30